Artificial intelligence could help pick the best embryos for IVF

NCT ID NCT07464275

Completed Diagnosis Sponsor: Future Fertility Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested an AI software called MAGENTA Blast that analyzes images of Day 3 embryos to predict which ones will develop into blastocysts by Day 5. Researchers looked at data from 76 women undergoing IVF to see if the tool could help embryologists make better decisions about which embryos to transfer or freeze. The goal is to improve success rates in fertility treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: MAGENTA Blast (AI software device)
What this could lead to: If validated, this AI tool could help embryologists choose the best embryos for IVF, potentially improving pregnancy success rates.
What could go wrong: This is a small, retrospective study (76 participants) that only tests prediction accuracy, not actual pregnancy outcomes. The tool may not work as well in real-time use or with different patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FERTILITY DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infertility disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FERTILITY DISORDERS INFERTILITY

Contacts and locations

Locations

Future Fertility

Toronto, Ontario, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.